Impact of Personalized Feedback Alone on Substance Use Behaviors

Substance Abuse Clinical Trial

Official title:

Brief Education to Reduce Health Care Consumers' Risky Substance Use Behaviors: How Brief is Brief?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01501318
• Other study ID #: 1200450
• Status: Completed
• Phase: N/A
• First received: December 23, 2011
• Last updated: September 29, 2016
• Start date: February 2012
• Est. completion date: November 2012

Study information

• Verified date: September 2016
• Source: University of Missouri-Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The investigators seek to develop a more efficient and effective approach to providing brief behavioral health interventions for risky substance use behaviors by comparing a brief coach directed intervention to a tailored report only group.

Description:

Screening and brief intervention (SBIRT) generally involves universal screening for risky substance use behaviors in medical settings and the immediate provision of a 3-15 minute intervention to those found to be at risk. In this pilot study, the investigators seek to develop a more efficient and effective approach to providing brief behavioral health interventions in the field by comparing a brief coach directed intervention to a tailored report only group. The goal is to create a cost-effective and sustainable system that provides consumers with tailored information that will help them both initiate and sustain the lifestyle changes necessary for improving their overall health.

Hypothesis 1: In a medical setting, personalized feedback alone will be associated with a reduction in risky substance use behaviors.

Hypothesis 2: In a medical setting, personalized feedback alone will have the same impact on behavior as that information plus a brief coach education session on risky substance use behaviors..

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: November 2012
• Est. primary completion date: November 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 105 Years

Eligibility

Inclusion Criteria:

• Low level risky substance use

Exclusion Criteria:

• high substance use risk levels

• potential alcohol or drug addiction or dependence

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Substance Abuse
• Substance-Related Disorders

Intervention

Behavioral:
• Personalized feedback report
Participants receive the personalized feedback report but no additional education.
• Personalized feedback report plus education
Participants receive the personalized feedback report plus education. This is the currently implemented service approach.

Locations

Country	Name	City	State
United States	University of Missouri Hospital ER	Columbia	Missouri

Sponsors (3)

Lead Sponsor	Collaborator
University of Missouri-Columbia	Institute of Mental Health, University of Missouri, St. Louis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Substance use behaviors and consequences	Interview questionnaire includes items concerning substance use behaviors (e.g., the number of drinks in the last 7 days) and consequences {e.g., ''During the past month, how often have you failed to do what was normally expected of you because of your use of alcohol?'	1 month follow-up	No
Secondary	Substance use behavioral intentions	Interview questionnaire that asks participants about their memory of the materials provided in the intervention, their motivation toward change, and their self-reported change efforts.	1 month follow-up	No